students enrolled in The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences formerly The University of Texas Graduate School of Biomedical Sciences at Houston (UT-GSBS), which it operates with UT Health Science Center at Houston. Areas of study include: Biochemistry & Cell Biology, Cancer Biology, Genetics & Epigenetics, Immunology, Medical Physics, Microbiology & Infectious Diseases, Neuroscience, Quantitative Sciences, and Therapeutics & Pharmacology. Additionally, the institution offers bachelor's and master's degrees to students enrolled in The UT MD Anderson Cancer Center School of Health Professions. Areas of study include clinical laboratory science, cytogenetic technology, cytotechnology, diagnostic imaging, diagnostic medical sonography, healthcare disparities, diversity and advocacy, histotechnology, medical dosimetry, molecular genetic technology, diagnostic genetics, radiological sciences and radiation therapy. Recognition In addition to its No. 1 ranking in cancer care by U.S. News & World Report, the cancer center ranks first in the number of National Cancer Institute grants and invested more than $862.8 million in research in FY 2018. The cancer center also has received Magnet Nursing recognition from the American Nurses Credentialing Center. In May 1996, the Pan American Health Organization (PAHO/WHO) established the Collaborating Center for Supportive Cancer Care at the Pain Research Group, The University of Texas M. D. Anderson Cancer Center. The terms of reference engage the Anderson Center in the development of palliative care programs throughout Latin America and the Caribbean. Presidents MD Anderson has had five full-time presidents in its history: R. Lee Clark, M.D. (1946–1978) Charles LeMaistre, M.D. (1978–1996) John Mendelsohn, M.D. (1996–2011) Ronald DePinho, M.D. (2011–2017) Peter WT Pisters, M.D. (2017–present) Mendelsohn stepped down from his position on Sept. 1, 2011, when Ronald A. DePinho, M.D., became president. Mendelsohn remained on the faculty as co-director of the new Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy. Mendelsohn died on January 7, 2019, from glioblastoma. Growth United States growth The cancer center continues to grow, increasing in size by 50% in the past 10 years. Presently, the Houston complex now includes more than 680 inpatient beds, several research buildings and outpatient clinic buildings, two faculty office buildings, and a patient-family hotel in addition to other off-site facilities for clinical and research use. Recently completed construction projects include two new research buildings on MD Anderson's South Campus and the addition of nine floors that can accommodate more than 300 new inpatient beds in Alkek Hospital on